@Halal May/Jun 2020 - Page 25

MAY-JUNE. 2020 | Glam Halal Health 25 Launching the symposium is Dato' Mahmud. Looking on is Prof Dato' Dr Imran. UNIVERSITI Kebangsaan Malaysia (UKM) through its Halal Pharmaceutical Business Initiatives (HPBI-UKM) in collaboration with Duopharma Biotech Berhad organised the ‘Halal Pharmaceutical Symposium 2020’ on Feb 25, 2020. The symposium was launched by Chairman of Halal Development Corporation (HDC) Dato’ Mahmud Abbas, Chairman of Halal Development Corporation (HDC). The symposium, with its theme “Fostering a Vibrant Halal Pharmaceutical Research and Academic Community” was to generate more research community and academicians on halal pharmaceuticals. This is in line with their agreement on strategic collaboration for research partnership signed last year. Duopharma is the first pharmaceutical company in Malaysia to obtain Halal Certification for Prescriptive Medicines based on the world’s first halal pharmaceutical standard, the MS2424. HPBI-UKM embodies UKM Graduate School of Business (GSB), the Faculty of Pharmacy (FFar), Faculty of Islamic Studies (FPI), UKM-UNIOEQ and Faculty of Science and Technology (FST). These forms of collaboration between universities and industries is line with a call made by the Ministry of Education to achieve a greater educational and technological development, skill development as well as management skills. According to the Deputy Vice-Chancellor of Industry and Community Partnerships of Universiti Kebangsaan Malaysia, Prof Dato’ Dr Imran Ho Abdullah, there were four research projects conducted, led by lecturers from GSB, FFar, FPI and FST. The research projects are fully funded through research grants provided by Duopharma totaling RM130,000. “I believe the implications of these four research projects is important to the government especially the Ministry of Health (MOH) Islamic enforcement agencies, hospitals, clinics, pharmacies, Pumping up more halal pharmaceutical research New innovations are needed for better optimisation of the halal value chain through collaborative events and also enhance the guidelines on halal medicines,” he added. The image of the halal pharmaceutical industry needs to be potrayed with care because the management of the halal value chain is increasingly critical. New innovations are needed for better optimization of halal value chains through collaborative events with various parties. Mahmud said, “At the moment, Malaysia’s contribution to the islamic global economy is only 0.47 per cent. Our contribution is a drop in the ocean. The growth of the halal pharmaceutical industry worldwide is huge. Its potential value of development Dato' Mahmud (middle) and Prof Dato' Dr Imran (left). At the moment, Malaysia’s contribution to the Islamic global economy is only 0.47 per cent.” — Mahmud Abbas is wide. When we look through the Islamic Global Economy Report 2018/2019, the expenditure on pharmaceutical products by Muslims in 2018 was up to US$92 billion. By 2024, the numbers are estimated to increase to US$134 billion.” The potential of the halal pharmaceutical is huge, but there is more work to be done by Malaysia. “Through this symposium, we will ensure there is a complete dissemination of information on the strategic development of the halal pharmaceutical industry. Major issues in halal value chain will also be put forth in order to have continuous improvements,” he said. UKM and Duopharma are hoping the Halal Pharmaceutical Symposium 2020 will be a great contribution to the halal pharmaceutical industry in the country and be a small step towards bigger collaborations.